Misiak et al. (11) reported a transdiagnostic activation pattern for MDD, SZ, and BD consisting of increased peripheral levels of IL-6, soluble interleukin receptor-2 (sIL-R2), TNF-α, and IL-1-receptor antagonist (IL-1RA) in acutely relapsed patients. This evidence concerns the gene TNF and Behcet disease.